Nollmann, F. I., & Ruess, D. A. (2020). Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising? Biomedicines.
Παραπομπή Chicago StyleNollmann, Friederike Inga, και Dietrich Alexander Ruess. "Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?" Biomedicines 2020.
Παραπομπή MLANollmann, Friederike Inga, και Dietrich Alexander Ruess. "Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?" Biomedicines 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.